The University of Kansas Cancer Center
The University of Kansas Cancer Center is an NCI-designated comprehensive cancer center and the only academic cancer center in Kansas, serving 4.6 million people across Kansas and western Missouri with comprehensive cancer care, clinical trials, and biomedical research.
- Company typePrivate
- Founded2012
- HeadquartersKansas City, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
What The University of Kansas Cancer Center does
The University of Kansas Cancer Center (KUCC) is an NCI-designated comprehensive cancer center and the only academic cancer center in the state of Kansas, operating as a non-profit public academic medical institution within the University of Kansas Medical Center system. Founded in 2012 when it received initial NCI cancer center designation, it was elevated to comprehensive designation in 2022, joining fewer than 60 such centers in the United States. KUCC serves a defined catchment area of 4.6 million people across all 105 Kansas counties and 18 western Missouri counties (92,000 square miles, 76% rural), addressing more than 25,000 annual cancer cases and 8,600 cancer deaths.
The center delivers comprehensive cancer care spanning chemotherapy, radiation therapy (including the first Proton Therapy Center in Kansas and the Kansas City region), brachytherapy, IMRT/IGRT, stereotactic radiosurgery, immunotherapy, cellular therapeutics, and CAR T-cell therapy, alongside multidisciplinary clinical care, genetic counseling, and survivorship programs. Research infrastructure includes the OPTIK data platform integrating Kansas and Missouri Cancer Registries, the Kansas Institute for Precision Medicine (renewed $11.6M COBRE grant), and consortium partnerships with Stowers Institute for Medical Research and Children's Mercy. Proprietary technology assets include advanced radiation modalities unavailable elsewhere in the region, the Ciclopirox prodrug (the first cancer center-invented drug to reach bedside), and CAR T-cell programs targeting solid tumors via novel polymer delivery.
Revenue is generated through clinical care billed through The University of Kansas Health System (insurance and financial assistance), federal research funding (NCI/NIH grants including the $11.6M COBRE), and philanthropy (Sprint Foundation, Hall Family Foundation, Kansas Masonic Foundation). Patient acquisition is hybrid: a sales-led motion via physician referrals and a dedicated physician relations team, supplemented by community-led engagement through the Masonic Cancer Alliance outreach network and community health educators targeting underserved and rural populations. Customer segments include cancer patients across the catchment area, underserved and health-equity populations (African American, Latino, Native American, rural), and referring physicians across the region.
The University of Kansas Cancer Center firmographics
Firmographics- Name
- The University of Kansas Cancer Center
- Legal name
- The University of Kansas Cancer Center
- Website
- https://kucancercenter.org
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- The University of Kansas Cancer Center is an NCI-designated comprehensive cancer center and the only academic cancer center in Kansas, serving 4.6 million people across Kansas and western Missouri with comprehensive cancer care, clinical trials, and biomedical research.
- Ownership category
- akta.pro rank
The University of Kansas Cancer Center industry classification
Industry- Product category
- Academic Cancer Center Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Other Outpatient Care Centers (62149), Diagnostic Imaging Centers (621512)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where The University of Kansas Cancer Center is headquartered
LocationHeadquarters
- HQ city
- Kansas City
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
The University of Kansas Cancer Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Clinical Care Services: The cancer center generates revenue through patient care services including cancer treatments (chemotherapy, radiation therapy, surgery, immunotherapy, cellular therapeutics), diagnostic services, and clinical consultations across multiple cancer types.
- Research Grants and Federal Funding: As an NCI-designated comprehensive cancer center, the institution receives significant funding from the National Cancer Institute and other National Institutes of Health entities. The Kansas Institute for Precision Medicine received a renewed $11.6 million COBRE grant from NIGMS/NIH over five years.
- Philanthropy and Donations: The cancer center raises funds through its 'Get Involved & Give' program, including major gifts from foundations (Sprint Foundation, Hall Family Foundation, Kansas Masonic Foundation) supporting endowed chairs, research programs, and facility construction.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Clinical care services billed through insurance or financial assistance programs |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels10 records
The University of Kansas Cancer Center product offering
Product offeringCore offering
The University of Kansas Cancer Center is an NCI-designated comprehensive cancer center providing diagnosis, treatment, and research for all cancer types. The center delivers chemotherapy, advanced radiation therapy (including proton therapy), immunotherapy, cellular therapeutics, and surgical oncology, supported by a Clinical Trials Office managing investigator-initiated and sponsored trials. It also operates a network of outreach, screening, genetic counseling, and survivorship programs across the Kansas and western Missouri region.
Product overview
The University of Kansas Cancer Center is an NCI-designated comprehensive cancer center offering a comprehensive suite of cancer care services centered around its Clinical Trials Office and research programs. The center provides treatment services including chemotherapy, radiation therapy, and proton therapy, supported by outreach through the Masonic Cancer Alliance network. Research infrastructure includes the OPTIK data platform, PIVOT patient advocacy program, and Kansas Institute for Precision Medicine. Educational programs include ACE and C-CLEAR summer research programs for high school and undergraduate students.
Differentiator
Problem solved
Functional benefit
Products and services
- Comprehensive Cancer Center Services NCI-designated comprehensive cancer center offering diagnosis, treatment, and research for all cancer types including breast, colorectal, gynecologic, lung, prostate, brain, blood disorders, and skin cancers.
- Proton Therapy Center Highly specialized radiation therapy using pencil-thin proton beams to target tumors while sparing surrounding healthy tissues. The first Proton Therapy Center in Kansas and the Kansas City region, combinable with X-ray/photon radiation therapy, chemotherapy, and surgery.
- Chemotherapy Drug-based cancer treatment delivered by infusion, pill form, or topically. Can be systemic or regional, used standalone or combined with other treatments.
- Radiation Therapy Cancer treatment using high-dose radiation including brachytherapy, IGRT, IMRT, proton therapy, and stereotactic radiosurgery/radiotherapy, with extensive regional experience in brachytherapy for prostate, breast, cervical, uterine, and vaginal cancers.
- Clinical Trials Program Portfolio of clinical trials including investigator-initiated studies and sponsored trials, providing infrastructure for research coordinators, regulatory specialists, and physician-investigators, with enrollment open to cancer patients.
- Masonic Cancer Alliance Outreach network connecting the cancer center with community partners across Kansas and western Missouri for cancer screening opportunities, education, and research coordination.
- Genetic Counseling and Testing Free genetic counseling and testing through the Center for Genetic Services and Health Equity, with referrals to cancer screening programs for high-risk individuals.
- OPTIK Data Platform Public-facing data platform synthesizing demographics, cancer risk factors, and incidence/mortality rates for Kansas and Missouri, collaborating with state cancer registries and health departments.
- Kansas Institute for Precision Medicine (KIPM) COBRE-funded research institute supporting junior investigators in precision medicine research with mentoring and pilot grants, backed by a renewed $11.6 million NIH/NIGMS COBRE grant over five years.
- Cellular Therapeutics and CAR T-cell Therapy Cellular therapy program offering CAR T-cell therapy and related novel immunotherapies, with active research into technologies to genetically modify T-cells to secrete cytokines for solid tumor treatment.
- Survivorship and Patient-Oriented Research Survivorship clinical services and the Center for Survivorship and Patient-Oriented Research, along with the PIVOT Patient Research Advocacy program uniting scientists and advocates for patient-centered research.
Quantifiable outcome
- NCI Comprehensive designation achieved in 2022, joining fewer than 60 elite cancer centers in the US
- +15 more outcomes
Companies that use The University of Kansas Cancer Center
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
The University of Kansas Cancer Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature6 records
The University of Kansas Cancer Center partnerships and signals
Strategic signalScale indicators6 records
Recent moves9 records
Expansion highlights6 records
The University of Kansas Cancer Center competitors and assessment
Company assessmentBroad incumbents
- Mayo Clinic Comprehensive Cancer Center: One of the largest NCI-designated comprehensive cancer centers in the US, anchored in Rochester, MN. Competes with KU for complex cases and faculty in the upper Midwest and offers broader national reach.
- MD Anderson Cancer Center: Premier global NCI-designated comprehensive cancer center. Sets the benchmark for cancer center scale, research output, and clinical trial volume, drawing patients and faculty from across the country including the KU catchment.
Direct peers
- University of Nebraska Medical Center / Fred & Pamela Buffett Cancer Center: NCI-designated cancer center serving a similarly rural, agricultural catchment in Nebraska and the surrounding Plains states. Directly comparable in mission, rural outreach focus, and NCI designation level.
- Vanderbilt-Ingram Cancer Center: NCI-designated comprehensive cancer center operating as part of a major academic medical center. Comparable in investigator-initiated trial portfolio, translational research, and NCI funding positioning.
- OU Health Stephenson Cancer Center: NCI-designated cancer center serving Oklahoma with a similarly rural catchment, disparities-driven mission, and state-university structure. Closely aligned with KU on rural community oncology research priorities.
- Masonic Cancer Center (University of Minnesota): NCI-designated comprehensive cancer center with overlapping Masonic philanthropic legacy and similar Big Ten-region academic model. Comparable in research depth, NCI designation tier, and consortium-based partnerships.
- University of Colorado Cancer Center: NCI-designated comprehensive cancer center serving Colorado and the Rocky Mountain region. Comparable as an academic-led NCI center balancing research, clinical care, and catchment-area outreach.
- Holden Comprehensive Cancer Center (University of Iowa): NCI-designated comprehensive cancer center serving Iowa and adjacent states with similar mid-sized catchment and academic medical center model. Comparable in scale, NCI designation level, and outreach demands.
- Siteman Cancer Center (Barnes-Jewish Hospital / Washington University): NCI Comprehensive Cancer Center in St. Louis that is the closest geographic direct peer to KU Cancer Center. Competes for complex oncology referrals, faculty recruitment, and cooperative group trial enrollment across the central Midwest.
Others
- Children's Mercy Hospital (Kansas City): NCI-approved Consortium Partner of KU Cancer Center for pediatric oncology since 2017. Highly relevant as the integrated pediatric arm of KU's cancer research and treatment delivery rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
The University of Kansas Cancer Center social profiles
Digital presenceThe University of Kansas Cancer Center compliance and trust
Trust signalCompliance2 records
The University of Kansas Cancer Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
The University of Kansas Cancer Center leadership team
Management profileNumber of profiles
Profiles14 records
The University of Kansas Cancer Center subsidiaries and ownership
Company hierarchySubsidiaries2 records
The University of Kansas Cancer Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The University of Kansas Cancer Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The University of Kansas Cancer Center
What does The University of Kansas Cancer Center do?
The University of Kansas Cancer Center is an NCI-designated comprehensive cancer center providing diagnosis, treatment, and research for all cancer types. The center delivers chemotherapy, advanced radiation therapy (including proton therapy), immunotherapy, cellular therapeutics, and surgical oncology, supported by a Clinical Trials Office managing investigator-initiated and sponsored trials. It also operates a network of outreach, screening, genetic counseling, and survivorship programs across the Kansas and western Missouri region.
Is The University of Kansas Cancer Center a public or private company?
The University of Kansas Cancer Center is a private company. It is classified as state government owned and is currently operating.
When was The University of Kansas Cancer Center founded?
The University of Kansas Cancer Center was founded in 2012. It employs 251 to 500 people.
Where is The University of Kansas Cancer Center based?
The University of Kansas Cancer Center is headquartered in Kansas City, United States, in the North America region.
How does The University of Kansas Cancer Center make money?
Three revenue lines are on record. Clinical Care Services are the primary driver. The others are research Grants and Federal Funding and philanthropy and Donations.
Who are The University of Kansas Cancer Center's main competitors?
Broad incumbents on record are Mayo Clinic Comprehensive Cancer Center and MD Anderson Cancer Center. Direct peers are University of Nebraska Medical Center / Fred & Pamela Buffett Cancer Center, Vanderbilt-Ingram Cancer Center, OU Health Stephenson Cancer Center, Masonic Cancer Center (University of Minnesota), University of Colorado Cancer Center, Holden Comprehensive Cancer Center (University of Iowa) and Siteman Cancer Center (Barnes-Jewish Hospital / Washington University). Children's Mercy Hospital (Kansas City) is listed as an others.
Does The University of Kansas Cancer Center have an API?
No public API is recorded for The University of Kansas Cancer Center.
What industry is The University of Kansas Cancer Center in?
The University of Kansas Cancer Center's product category is Academic Cancer Center Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8000.